Cameron Sellers
Cameron Sellers is a Vice President at Creandum, a Stockholm-based venture capital firm, where he focuses on early-stage investments with an emphasis on frontline, fintech, and healthcare sectors. He is best known for leading Creandum's largest single investment to date in EquiLibre Technologies, a Prague-based AI lab founded by former DeepMind researchers that applies reinforcement learning to quantitative trading. Prior to joining Creandum in early 2025, he co-founded Zola Health, a vertical SaaS platform for elderly care homes, and previously worked in healthcare investment banking at Deutsche Bank and as a co-founder and equity analyst at Mountain Pass Capital. He holds an MPhil in Bioscience Enterprise from the University of Cambridge and a bachelor's degree from the University of Oxford.
“EquiLibre Technologies valued at $500M after a record Series A from Creandum; applying reinforcement learning from poker AI to live equity and crypto markets.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.